Tango Therapeutics Inc (TNGX)

EBITDA

-$121.86M

TTM · Period ending: · USD

TNGX logo

TNGX EBITDA

Latest reported-$121.86M
TNGX TTM EBITDA (-$51.41M → -$121.86M)
High-resolution chart · PNG

TNGX ebitda history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Tango Therapeutics Inc EBITDA — Trailing twelve months (TTM) (USD)
Period endingEBITDA (USD)
-121,861,000
-105,139,000
-99,309,000
-97,985,000
-142,905,000
-129,566,000
-127,595,000
-120,693,000
-113,829,000
-109,017,000
-99,195,000
-97,535,000
-104,541,000
-109,042,000
-106,514,000
-99,688,000
-90,358,000
-70,117,000
-57,046,000
-44,107,000
-51,374,000
-55,338,000
-51,410,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.